セッション詳細

[WS(P)04]Innate Immunity 1: Innate inflammation and disease

2024年12月3日(火) 16:50 〜 17:35
Poster 4

[WS04-01-P]Soluble form of the MDA5 protein in human sera

Tomoaki Hoshino (Department of Medicine 1, Kurume University School of Medicine)

[WS04-02-O/P]Nucleolar dysfunction leads to the XPG-dependent generation of RNA-DNA hybrids, which prime the innate immune response underlying ribosomal diseases via the cGAS-STING pathway

Ken Takashima, Hiroyuki Oshiumi (Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Science, Kumamoto University)

[WS04-03-P]Immunomodulatory activity of a water-soluble crude extracts obtained from Coix lacryma-jobi var. ma-yuen on immune cells

Susumu Tomono1, Masaaki Yoshida2, Yinzhi Lin1, Sachiko Akashi-Takamura1 (1.Department of Microbiology and Immunology, School of Medicine, Aichi Medical University, 2.Kotaro pharmaceutical Co., Ltd)

[WS04-04-P]Impact of cholic acid on the development of iHFC diet-induced MASH in mice

Kana Goto1, Yukihiro Furusawa1, Koichi Tsuneyama2, Yoshinori Nagai1 (1.Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 2.Department of Pathology and Laboratory Medicine, Tokushima University Graduate School)

[WS04-05-P]Impact of iHFC diet on pathological changes of type 2 diabetes and MASH in type 2 diabetic TSOD mice

Miyuna Kato1, Yukihiro Furusawa1, Koichi Tsuneyama2, Yoshinori Nagai1 (1.Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 2.Department of Pathology and Laboratory Medicine, Tokushima University Graduate School)

[WS04-06-P]RNaseT2-deficiency promotes TLR13-dependent replenishment of tissue-protective Kupffer cells

Ryota Sato1, Kaiwen Liu1, Takuma Shibata1, Ryutaro Fukui1, Yuji Motoi1, Toshikazu Kondo2, Toru Miyazaki3, Tsuneyasu Kaisho4, Kensuke Miyake1 (1.Division of Innate Immunity, The Institute of Medical Science, The University of Tokyo, 2.Department of Forensic, Wakayama Medical University, 3.The Institute for AIM Medicine, 4.Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University)

[WS04-07-O/P]The role of small neutral amino acid transport in macrophage metabolic reprogramming during inflammation.

Shota Yasukura1, Masanori Yoshinaga1, Michael C Bassik2, Osamu Takeuchi1 (1.Department of Medical Chemistry Graduate School of Medicine, Kyoto University, 2.Department of Genetics, Bassik Lab, Stanford University School of Medicine, Stanford CA, USA)

[WS04-08-P]Role of Nuclear factor-Y in NLRC5-mediated MHC class I gene expression

Zufang Wu1, Tsutomu Tanaka1, Xin Sun1, Ning An1, Koichi S Kobayashi1,2,3 (1.Department of Immunology, Hokkaido University Graduate School of Medicine, 2.Department of Microbial Pathogenesis and Immunology, 3.Hokkaido University Institute for Vaccine Research and Development)

[WS04-09-O/P]Low-level Endotoxin Preconditioning after Burn Injury Significantly Improves Survival Rate in Mouse Sepsis Model

Bradley M. Kearney1,2, Hiroyuki Nakashima1, Masahiro Nakashima1, Hiromi Miyazaki1, Kohei Yamada1, Kazuma Mori1, Azusa Kato1, Takeshi Ono1, Hiroyasu Goto1, Ryohei Suematsu1, Manabu Kinoshita1 (1.National Defense Medical College, 2.US Army Japan Engineer and Scientist Exchange Program)

[WS04-10-P]Wdfy4 is indispensable for the development of TLR7-induced lethal hepatitis model

Yusuke Murakami1, Ryutaro Fukui2, Tomoya Narita1, Reika Tanaka2, Kosuke Zenke1, Masashi Muroi1, Keiki Kumano1, Kensuke Miyake2 (1.Musashino university, 2.University of Tokyo)

[WS04-11-P]The cytokine component Epstein-Barr virus induced 3 attributes to TLR7-mediated splenomegaly and bicytopenia

Masanori Iseki1, Yuma Sakamoto1, Daiki Takezaki1,2, Yoshihiro Matsuda1,2, Mariko Inoue3, Shin Morizane2, Tomoyuki Mukai1 (1.Department of Immunology and Molecular Genetics, Kawasaki Medical School, 2.Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 3.Medical Bioresource Research Unit, Central Research Institute, Kawasaki Medical School)

[WS04-12-P]Fibrinogen induces inflammatory responses via the immune activating receptor LILRA2.

Yifan Li1,2, Kouyuki Hirayasu1,2, Gen Hasegawa1,2, Yosei Tomita1,2, Yuko Hashikawa1,2,3, Ryosuke Hiwa4, Hisashi Arase5,6,7,8, Rikinari Hanayama2,3 (1.Department of Evolutionary Immunology, Advanced Preventive Medical Sciences Research Center, Kanazawa University, Kanazawa, Ishikawa 920-8640, Japan, 2.Department of Immunology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa 920-8640, Japan, 3.WPI Nano Life Science Institute (NanoLSI), Kanazawa University, Kanazawa, Ishikawa 920-1192, Japan, 4.Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan, 5.Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan, 6.Laboratory of Immunochemistry, WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan, 7.Center for advanced modalities and DDS, Osaka University, Osaka, 565-0871, Japan., 8.Center for Infectious Disease Education and Research, Osaka University, Osaka, 565-0871, Japan.)

[WS04-13-P]Enhancement of adjuvant activity of phosphodiester-linked IFN-α-inducible CpG oligonucleotide G9.1 in combination with protein

Jun-ichi Maeyama1, Fumiko Suzuki2, Sumiko Iho3, Yuriko Ozeki4, Sohkichi Matsumoto4, Saburo Yamamoto1 (1.National Institute of Infectious Diseases, 2.Faculty of Medical Sciences, University of Fukui, 3.Louis Pasteur Center for Medical Research, 4.School of Medicine, Niigata University)

[WS04-14-O/P]K3-SPG-mediated long-term protection against viral infection

Asuka Joy Tobuse1, Kouji Kobiyama1,2, Jun Tsuchida1, Teppei Hara1, Yaeko Nakajima-Takagi4, Motohiko Oshima4, Tomoya Hayashi1, Burcu Temizoz1, Hideo Negishi1, Yasuhiro Yasutomi3, Atsushi Iwama4, Ken J Ishii1,2 (1.Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, 2.International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, 3.Laboratory of Immunoregulation and Vaccine Research, Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition, 4.Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, University of Tokyo, Tokyo, Japan)

[WS04-15-O/P]Structural insights into the IgM-CD5L complex and its impact on resolution of inflammation through DAMPs recognition

Satoko Arai, Toru Miyazaki (The Institute for AIM Medicine)

[WS04-16-O/P]Tissue-specialized alveolar fibroblasts adopt multiple molecular states to regulate innate immunity after lung injury

Tatsuya Tsukui, Paul J Wolters, Dean Sheppard (Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California, San Francisco)

[WS04-17-O/P]Myd88/Trif signaling is necessary for neurological recovery after stroke

Ryuki Koyama, Shichita Takashi, Jun Tsuyama (Tokyo Medical and Dental University Medical Research Institute Department of Neuroinflammation and Repair)

[WS04-18-O/P]Anti-amyloid-beta antibody restores the post-stroke neural reparative function impaired by amyloid-beta pathology

Kento Otani1,2, Eri Tanaka1,2, Koji Hase2, Takashi Saito3, Takashi Shichita1 (1.Department of Neuroinflammation and Repair, Medical Research Institute, Tokyo Medical and Dental University, 2.Department of Biochemistry, Graduate School of Pharmaceutical Sciences, Keio University, 3.Department of Neurocognitive Science, Institute of Brain Science, Graduate School of Medical Sciences, Nagoya City University)

[WS04-19-P]Adjunctive treatment of mitochondrial uncoupler BAM15 attenuates sepsis-related acute lung injury partly through the reduction of neutrophil inflammation

Kritsanawan Sae-khow, Awirut Charoensappakit, Asada Leelahavanichkul (Center of Excellence on Translational Research in Inflammation and Immunology (CETRII), Faculty of Medicines, Chulalongkorn University, Bangkok 10330, Thailand)

[WS04-20-P]Citrullinated histone H3 as a potential biomarker for monitoring intubated patients with sepsis-related acute respiratory distress syndrome.

Awirut Charoensappakit1, Kritsanawan Sae-khow1, Patinya Maneesow2, Nuntanuj Vutthikraivit2, Monvasi Pecheenbuvan2, Asada Leelahavanichkul1,3 (1.Center of Excellence on Translational Research in Inflammation and Immunology (CETRII), Faculty of Medicines, Chulalongkorn University, Bangkok 10330, Thail, 2.Division of Critical Care Medicine, Department of Internal Medicine, Chulalongkorn University, Bangkok 10330, Thailand, 3.Immunology unit, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand)